(Q45028602)

8 December 2017

title

Fatigue in multiple sclerosis: multidimensional assessment and response to symptomatic treatment (English)

1 reference

8 December 2017

0 references

2

Roberto Bergamaschi

1 reference

8 December 2017

Alfredo Romani

1

1 reference

8 December 2017

Elisa Candeloro

3

1 reference

8 December 2017

Enrico Alfonsi

4

1 reference

8 December 2017

Roberto Callieco

5

1 reference

8 December 2017

Vittorio Cosi

6

1 reference

8 December 2017

publication date

1 August 2004

1 reference

Multiple Sclerosis Journal

8 December 2017

published in

1 reference

8 December 2017

volume

10

1 reference

8 December 2017

issue

4

1 reference

8 December 2017

page(s)

462-468

1 reference

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors.

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Fatigue in multiple sclerosis: definition, pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

An electrophysiological study of the mechanism of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

New perspectives on neurochemical effects of amantadine in the brain of parkinsonian patients: a PET - [(11)C]raclopride study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Modafinil increases histamine release in the anterior hypothalamus of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Relationships between parts A and B of the Trail Making Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Cognitive disturbances in patients with relapsing remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Fatigue and declines in cognitive functioning in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

'Fatigue' in patients with multiple sclerosis. Motor pathway conduction and event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Nervous propagation along 'central' motor pathways in intact man: characteristics of motor responses to 'bifocal' and 'unifocal' spine and scalp non-invasive stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

4-Aminopyridine in Patients with Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

Effects of 4-aminopyridine on cardiac repolarization, PR interval, and heart rate in patients with spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1051OA

10.1191/1352458504MS1051OA

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference